{"title":"用底物DNP-α-GalNAc检测人血清中多种外显糖苷酶。2三个α- n -乙酰半乳糖胺酶样活性在pH 5 ~ 8区域","authors":"Simon P.J. Albracht , Johannes van Pelt","doi":"10.1016/j.bbacli.2017.09.002","DOIUrl":null,"url":null,"abstract":"<div><p>With the substrate DNP-α-GalNAc (2,4-dinitrophenyl-<em>N</em>-acetyl-α-<span>d</span>-galactosaminide) three α-<em>N</em>-acetylgalactosaminidase-like activities could be distinguished in serum, in addition to the classical lysosomal enzyme (Naga, EC 3.2.1.49, pH optimum at 4). Two activities had optima in the pH<!--> <!-->5 to 6 region and one peaked around pH<!--> <!-->8. Like the Naga activity at pH<!--> <!-->4, the activity at pH<!--> <!-->8 was detectable under standard assay conditions. However, the two activities in the pH<!--> <!-->5 to 6 range were not readily apparent in such assays. They could be unmasked as separate activities only when low serum concentrations were used. Addition of 1% saturated ammonium sulphate to the assay medium stimulated these activities. All activities in the pH<!--> <!-->5 to 8 range decreased with increasing serum concentration in the assay, suggesting the presence of endogenous inhibitors. The activities between pH<!--> <!-->5 and 6 might be similar to an activity described in 1996, which was considerably elevated in serum of patients with great variety of cancers (N. Yamamoto, V.R. Naraparaju, and S.O. Asbell (1996). Deglycosylation of serum vitamin D<sub>3</sub>-binding protein leads to immunosuppression in cancer patients. Cancer Res. 56, 2827–2831).</p></div>","PeriodicalId":72344,"journal":{"name":"BBA clinical","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bbacli.2017.09.002","citationCount":"5","resultStr":"{\"title\":\"Multiple exo-glycosidases in human serum as detected with the substrate DNP-α-GalNAc. II. Three α-N-acetylgalactosaminidase-like activities in the pH 5 to 8 region\",\"authors\":\"Simon P.J. Albracht , Johannes van Pelt\",\"doi\":\"10.1016/j.bbacli.2017.09.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>With the substrate DNP-α-GalNAc (2,4-dinitrophenyl-<em>N</em>-acetyl-α-<span>d</span>-galactosaminide) three α-<em>N</em>-acetylgalactosaminidase-like activities could be distinguished in serum, in addition to the classical lysosomal enzyme (Naga, EC 3.2.1.49, pH optimum at 4). Two activities had optima in the pH<!--> <!-->5 to 6 region and one peaked around pH<!--> <!-->8. Like the Naga activity at pH<!--> <!-->4, the activity at pH<!--> <!-->8 was detectable under standard assay conditions. However, the two activities in the pH<!--> <!-->5 to 6 range were not readily apparent in such assays. They could be unmasked as separate activities only when low serum concentrations were used. Addition of 1% saturated ammonium sulphate to the assay medium stimulated these activities. All activities in the pH<!--> <!-->5 to 8 range decreased with increasing serum concentration in the assay, suggesting the presence of endogenous inhibitors. The activities between pH<!--> <!-->5 and 6 might be similar to an activity described in 1996, which was considerably elevated in serum of patients with great variety of cancers (N. Yamamoto, V.R. Naraparaju, and S.O. Asbell (1996). Deglycosylation of serum vitamin D<sub>3</sub>-binding protein leads to immunosuppression in cancer patients. Cancer Res. 56, 2827–2831).</p></div>\",\"PeriodicalId\":72344,\"journal\":{\"name\":\"BBA clinical\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.bbacli.2017.09.002\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BBA clinical\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2214647417300351\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BBA clinical","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2214647417300351","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5
摘要
以DNP-α-GalNAc(2,4-二硝基苯- n -乙酰-α-d-半乳糖胺)为底物,除经典溶酶体酶(Naga, EC 3.2.1.49, pH在4时最适)外,血清中还可区分出3种α- n -乙酰半乳糖胺酶样酶活性,其中2种酶活性在pH 5 ~ 6时达到最佳,1种酶活性在pH 8时达到峰值。与Naga在pH值4时的活性一样,在pH值8时的活性在标准测定条件下可检测到。然而,在pH值为5到6的范围内,这两种活性在这种测定中并不明显。只有当使用低血清浓度时,它们才能被发现为单独的活性。在实验培养基中加入1%的饱和硫酸铵刺激了这些活性。pH值5 ~ 8范围内的所有活性随着血清浓度的增加而降低,提示存在内源性抑制剂。pH值在5到6之间的活性可能与1996年描述的一种活性相似,这种活性在多种癌症患者的血清中显著升高(N. Yamamoto, V.R. Naraparaju和S.O. Asbell(1996))。肿瘤患者血清维生素d3结合蛋白去糖基化导致免疫抑制。巨蟹座,56,2827-2831)。
Multiple exo-glycosidases in human serum as detected with the substrate DNP-α-GalNAc. II. Three α-N-acetylgalactosaminidase-like activities in the pH 5 to 8 region
With the substrate DNP-α-GalNAc (2,4-dinitrophenyl-N-acetyl-α-d-galactosaminide) three α-N-acetylgalactosaminidase-like activities could be distinguished in serum, in addition to the classical lysosomal enzyme (Naga, EC 3.2.1.49, pH optimum at 4). Two activities had optima in the pH 5 to 6 region and one peaked around pH 8. Like the Naga activity at pH 4, the activity at pH 8 was detectable under standard assay conditions. However, the two activities in the pH 5 to 6 range were not readily apparent in such assays. They could be unmasked as separate activities only when low serum concentrations were used. Addition of 1% saturated ammonium sulphate to the assay medium stimulated these activities. All activities in the pH 5 to 8 range decreased with increasing serum concentration in the assay, suggesting the presence of endogenous inhibitors. The activities between pH 5 and 6 might be similar to an activity described in 1996, which was considerably elevated in serum of patients with great variety of cancers (N. Yamamoto, V.R. Naraparaju, and S.O. Asbell (1996). Deglycosylation of serum vitamin D3-binding protein leads to immunosuppression in cancer patients. Cancer Res. 56, 2827–2831).